• woman and doctor talking about brixadi

FDA Approves Brixadi for Medication-Assisted Treatment

The U.S. Food and Drug Administration (FDA) has approved BRIXADI,  also known as buprenorphine, for people with moderate to severe opioid use disorder. The drug is an extended-release injection for subcutaneous use (CIII), meant to be taken weekly or monthly at a healthcare provider’s office. Brixadi is a form of Medication-Assisted Treatment meant to help

  • image of a skeptical-looking doctor

Buprenorphine is Under-Prescribed Due to Hurdles, Mistrust

Medication-assisted Treatment (MAT) can be a lifeline for those who are addicted to opioids and struggle with long-term cravings and short-term withdrawal symptoms. However, research by NPR shows that doctors and pharmacists mistrust the drug, resulting in few people seeking help with addiction gaining access to it. Doctors Have Little Incentive to Prescribe Buprenorphine Buprenorphine,

  • doctor prescribing adderall to a young female student

Prison Medication-Assisted Treatment Program Leads to 60% Decrease in OD’s

This week, New York City Mayor Michael Bloomberg and Gov. Gina Raimondo's took a tour of the facilities for inmates and people involved in the post-incarceration program. Gov. Raimondo then participated in a roundtable discussion about the state's medication-assisted treatment program. Introduced in 2017, the program offers inmates in the prison system, also called AC)